Gemcitabine and XCT790, an ERRα inverse agonist, display a synergistic anticancer effect in pancreatic cancer

por Liu, Shi-lei, Liang, Hai-bin, Yang, Zi-yi, Cai, Chen, Wu, Zi-you, Wu, Xiang-song, Dong, Ping, Li, Mao-lan, Zheng, Lei, Gong, Wei
Publicado 2022

The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR

por Zhao, Shuai, Cao, Yang, Liu, Shi-bo, Wang, Xu-an, Bao, Run-fa, Shu, Yi-jun, Hu, Yun-ping, Zhang, Yi-jian, Jiang, Lin, Zhang, Fei, Liang, Hai-bin, Li, Huai-feng, Ma, Qiang, Xu, Yi, Wang, Zheng, Zhang, Yi-chi, Chen, Lei, Zhou, Jian, Liu, Ying-bin
Publicado 2016

miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma

por Bao, Run-Fa, Shu, Yi-Jun, Hu, Yun-Ping, Wang, Xu-An, Zhang, Fei, Liang, Hai-Bin, Ye, Yuan-Yuan, Li, Huai-Feng, Xiang, Shan-Shan, Weng, Hao, Cao, Yang, Wu, Xiang-Song, Li, Mao-Lan, Wu, Wen-guang, Zhang, Yi-Jian, Jiang, Lin, Dong, Qian, Liu, Ying-Bin
Publicado 2016